State Street Corp Opiant Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.0 - $21.1 $0 - $339,393
-16,085 Closed
0 $0
Q4 2022

Feb 14, 2023
BUY
$9.38 - $20.29 $26,264 - $56,812
2,800 Added 21.08%
16,085 $326,000
Q1 2022

May 16, 2022
BUY
$19.54 - $33.59 $25,108 - $43,163
1,285 Added 10.71%
13,285 $285,000
Q4 2021

Feb 14, 2022
BUY
$22.51 - $36.79 $270,120 - $441,480
12,000 New
12,000 $404,000

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email